ArticleScientific reports2026
An explainable ensemble learning-based auxiliary diagnosis system for cerebral small vessel disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cerebral small vessel disease (CSVD) poses major public health challenges, yet current MRI based diagnosis detects only established damage, and existing auxiliary methods, mostly based on conventional statistics, lack sufficient feature extraction capability and generalizability, thereby limiting early warning and precision management. Accordingly, we developed an intelligent auxiliary diagnostic system grounded in an interpretable ensemble learning framework, aiming to enable early detection and warning of CSVD. To support this development, a total of 597 sets of electronic medical record data from Quzhou Affiliated Hospital of Wenzhou Medical University were used as the study cohort. Firstly, a multidimensional feature evaluation and selection method was proposed, identifying 12 key predictive factors out of 23 relevant variables. Subsequently, the optimal algorithm was selected from Logistic Regression, Decision Tree, Random Forest, Support Vector Machine, Gradient Boosting Machine, XGBoost, and Multilayer Perceptron Classifier, based on Area Under the Curve (AUC) and Accuracy metrics, and a stacking ensemble learning strategy was then employed for model construction. The developed model demonstrated excellent discriminative performance, achieving an AUC of 0.881 while maintaining a low Brier score of 0.1271. By integrating the SHAP interpretability algorithm, the model provided intuitive visualizations of feature importance, thereby enhancing transparency and facilitating clinical adoption. Ultimately, this study achieved effective integration of early warning and auxiliary diagnostic functions for CSVD. These results indicate that the proposed system possesses high accuracy, interpretability, and deployability, underscoring its broad potential for early warning and personalized management of CSVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.